Oral Appliance for Sleep Apnea: Success Rates vs CPAP, Hours Worn and Side Effects (2026)

CPAP is the standard treatment for obstructive sleep apnea, and for many people it does not last. Depending on the study, 46 to 83% of CPAP patients have been reported to use the machine for less than four hours a night (Weaver and Grunstein, 2008), and in a national French database of nearly half a million users, 47.7% had stopped within three years (Pepin et al., 2021). For most of those patients the next step is a custom mouthpiece that holds the lower jaw forward during sleep, the kind of sleep apnea treatment a dentist fits and adjusts.

The question patients ask first is whether a mouthpiece works as well as the machine. The research gives a two-part answer. Hour for hour, CPAP removes more breathing events. Night for night, the gap mostly closes, because people keep a mouthpiece in for longer. The bigger risk sits somewhere almost nobody looks: once the device is fitted, few patients ever get a sleep test to prove it is still doing its job.

This page brings together figures from the joint sleep and dental guideline, randomized trials published as recently as this year and cohorts followed for up to a decade. Every number links to the study it came from.

How Often Does a Sleep Apnea Mouthpiece Work? About Half Reach Full Control

About half the time, if working means near-normal breathing. A review of the evidence put complete control, fewer than five breathing events an hour, at 48% of patients (Sutherland et al., 2014). Looser definitions push the figure higher: 76.2% of patients who could not tolerate CPAP halved their apnea score on a custom device (Vecchierini et al., 2016).

Sleep apnea is graded by the apnea-hypopnea index, or AHI: the number of times an hour breathing stops or turns shallow. Mild, moderate and severe are the usual bands, and the signs and types of sleep apnea matter because severity changes the odds. In a clinic of nearly five hundred patients fitted with an adjustable appliance, 70.3% of mild cases reached near-normal breathing, against 47.6% of moderate and 41.4% of severe cases (Holley et al., 2011). An older review that used a looser bar, ten events an hour or fewer, found success in 52% of treated patients (Ferguson et al., 2006).

Success rates swing widely because studies define success differently, so a figure only means something next to its definition. Measured as the average drop in the apnea score, mouthpieces do well at every level: a meta-analysis of more than two thousand patients found the score fell by 58% in mild, 67% in moderate and 66% in severe sleep apnea (Liao et al., 2024). Against no treatment at all, the guideline's pooled analysis put the reduction at 13.60 events an hour (Ramar et al., 2015). Most patients improve a lot; roughly half reach full control.

Is a Mouthpiece as Good as CPAP? Per Hour, No. Per Night, Nearly

CPAP removes more breathing events while it is on: 6.24 more an hour across head-to-head randomized trials (Ramar et al., 2015). But a device only treats apnea while it is in, and mouthpieces stay in longer. Counting hours worn, one study found a mouthpiece removed 49.9% of apnea over the night, against 49.1% for CPAP (Dieltjens et al., 2026).

Measured with the device in for a full sleep study, CPAP wins clearly. In a randomized crossover trial where patients used each treatment for a month, the apnea score was 4.5 on CPAP and 11.1 on the mouthpiece (Phillips et al., 2013). A meta-analysis of the head-to-head trials put the average gap at 7.03 events an hour (Sharples et al., 2016), and in the large clinic series above, 70.1% of patients reached near-normal breathing on CPAP against 51.6% on the appliance (Holley et al., 2011).

Those numbers assume the treatment is used all night, every night. Researchers correct for that with mean disease alleviation, which multiplies how well a treatment works by the share of the night it is used. On that measure the two come out close. In ninety-four patients who used both, the mouthpiece removed 49.9% of apnea and CPAP 49.1% (Dieltjens et al., 2026); everyone tried the mouthpiece first, so the study was not randomized. An earlier cohort with a heat sensor in each device reached a similar 51.1% (Vanderveken et al., 2013). Blood pressure tells the same story: a network meta-analysis found a difference of only -0.5 mm Hg between the two (Bratton et al., 2015), and in a trial of patients with high blood pressure, it fell by 2.5 mm Hg on the mouthpiece over six months but did not change on CPAP (Ou et al., 2024).

How Many Hours a Night Do People Wear Each One?

Longer for the mouthpiece in every head-to-head trial reviewed here. Pooled across randomized trials that measured use with sensors, people wore a mouthpiece 0.71 h longer than CPAP (Cheng et al., 2026). Across twenty years of CPAP studies, average use was 4.6 h a night (Rotenberg et al., 2016), well short of a full night's sleep.

The wear-time advantage shows up whether patients report their own use or a sensor records it. In a crossover trial, patients reported 6.50 h a night on the mouthpiece and 5.20 h on CPAP (Phillips et al., 2013); in a newer trial with objective tracking, the figures were 6.0 and 5.3 hours (Hamoda et al., 2025), and the one-year results of a large blood pressure trial showed a median of 5.5 hours on the mouthpiece against 4.9 on CPAP (Ou et al., 2026). Among patients with severe apnea in that trial, 56.1% of mouthpiece users reached six hours or more, against 28.3% on CPAP (Colpani et al., 2026). Fit drives much of this: a device made from digital impressions of your teeth sits better and is easier to wear all night.

Over years, the picture evens out. In one sensor-tracked group only 9.8% of mouthpiece users quit within the first year (Dieltjens et al., 2013), and a Paris cohort found 63% still in treatment after about three years (Attali et al., 2016). Among long-term users who stopped, 44.4% blamed discomfort (de Almeida et al., 2005). A randomized trial that tracked patients for a decade found 35% still on their mouthpiece and 46% still on CPAP (Uniken Venema et al., 2020), the one long study where CPAP held on better. Patients also choose: after trying both, 51% preferred the mouthpiece (Dieltjens et al., 2026). When comfort is the problem, in-office 3D printing can make an adjusted device faster.

What Side Effects Do Mouthpieces Cause? About One in Three Get Extra Saliva

Mostly mild and mostly early. Across studies with at least six months of follow-up, the most common were extra saliva (33.3%), bite changes (30.2%) and jaw muscle pain (22.9%) (Mansour et al., 2024). Jaw-joint pain was more common early on with a mouthpiece than with CPAP, 24% against 6%, and it tended to pass (Doff et al., 2012).

Most early side effects fade as the jaw and teeth adjust. A systematic review found tooth discomfort in 20.2% of users and dry mouth in 18.3% (Mansour et al., 2024). Jaw-joint pain matters most because it can make someone quit, and a dentist who also provides TMJ treatment can adjust the advancement before it becomes a reason to stop. It also helps to know what you are wearing: a sleep apnea device holds the jaw forward, while ordinary night guards only protect teeth from grinding and do nothing for the airway.

The slower change is to the bite itself. In a group followed for about eleven years, the overbite shrank by 2.3 millimetres on average, 51% developed back teeth that no longer met and 62% had at least one front tooth in crossbite (Pliska et al., 2014). The changes kept progressing, so the bite should be checked for as long as the device is worn. Devices also wear out. A study published this month followed two hundred and nineteen patients for a median of almost four years: 26.5% needed a whole new device because the old one broke, and 81.1% got through three years without a breakage remake (Kakuda et al., 2026). That study covered one clinic and one device design, so the rate for other devices may differ.

Feeling Better Is Not Proof: How Many Mouthpiece Patients Ever Get Retested?

Few. At one large American dental sleep practice, only 22% of patients had a sleep test both before and after treatment (Mintz and Kovacs, 2018). That matters because symptoms mislead: at Mayo Clinic, 89% of snoring patients said their snoring had largely stopped, yet only about 20% of patients reached fewer than ten breathing events an hour (Hamza et al., 2026).

The joint guideline from the sleep and dental academies advises a follow-up sleep test after an oral appliance is fitted, rather than relying on how the patient feels (Ramar et al., 2015). Practice falls short. An older survey of dentists who treat sleep apnea found only 18% of patients got a sleep study with the device in (Loube and Strauss, 1997), and a ten-centre Japanese study reassessed 54.3% (Okuno et al., 2019). Where patients were retested, results were good: 90% of the retested group in the American practice reached fewer than ten events an hour (Mintz and Kovacs, 2018). The problem is everyone who was never measured. Quieter nights and more energy feel like proof, and they are not. When devices were adjusted by symptoms alone, 65.2% of patients reached the success bar, and those still under-treated reported the same improvement as those who were controlled (Almeida et al., 2009). In another group, 12.24% were worse on the device even though most said they felt better (Sangalli et al., 2022).

The device can also lose ground over time. A cohort that tracked custom devices for five years found 52% still met the success bar, down from a higher share in the first months (Vecchierini et al., 2021). A smaller study of long-term users measured the apnea score creeping up by 0.7 events an hour each year with the device in (Buiret and Chidiac, 2020); it came from one clinic and one device brand, so treat it as a warning sign rather than a settled rate. The practical step: ask for a sleep test with the device in once it is adjusted, and again if symptoms return, weight changes or the device is remade. Between tests, routine cleanings and exams are the natural time to check fit and bite, which is one more reason how often you visit the dentist matters for sleep apnea patients.

Who Is a Good Candidate, and What Will Medicare Cover?

People with mild to moderate apnea, women, and those whose apnea happens mostly on their back tend to do best, and a custom device beats an over-the-counter one. In a randomized crossover trial, a custom device succeeded in 60% of patients against 31% for a boil-and-bite device (Vanderveken et al., 2008). Medicare covers a custom device from a dentist when a sleep test qualifies.

In a cohort of more than six hundred patients, women had 2.4 times the odds of success that men did, and men whose apnea occurred mainly when lying on their back had 6.0 times the odds (Marklund et al., 2004). Custom construction matters too. The guideline's pooled analysis found custom devices cut the apnea score by 13.89 events an hour, while the few trials of non-custom devices showed 6.28, a result that was not statistically significant (Ramar et al., 2015). The guideline itself recommends a custom, adjustable device made by a qualified dentist. A practice that invests in modern dental technology can scan, make and adjust that device in-house.

Medicare covers a custom oral appliance supplied by a dentist when a sleep test shows 15 events per hour or more, or a milder score with symptoms such as daytime sleepiness or high blood pressure; above an AHI of thirty, the patient must also be unable to tolerate CPAP (CMS LCD L33611, 2021). Financial options cover what insurance does not. One newer choice: the FDA approved tirzepatide, sold as Zepbound, for moderate to severe sleep apnea in adults with obesity on December 20, 2024 (U.S. Food and Drug Administration, 2024), and in its trials the apnea score fell by -25.3 events an hour against -5.3 on placebo (Malhotra et al., 2024). For people without obesity, a mouthpiece remains the main alternative to CPAP. The larger gap is diagnosis: an estimated 23,678,109 American adults aged thirty to sixty-nine have moderate to severe sleep apnea (Benjafield et al., 2019), and 80% of people with the condition are undiagnosed (American Academy of Sleep Medicine, 2016). At Above & Beyond Dental in Borger, Dr. Robertson fits custom oral appliances for sleep apnea and adjusts them at follow-up visits, and the research above is why any device should be confirmed with a follow-up sleep test. If you snore, wake unrested or have been told you stop breathing at night, book a sleep apnea consultation with Dr. Robertson.

Frequently Asked Questions

How well do dental mouthpieces work for sleep apnea?

For most people, well enough to matter. A 2014 review put complete control (fewer than 5 events an hour) at about 48% of patients, and in one clinic of 497 patients 70.3% of mild cases reached that bar. Severe cases do less well, at 41.4% in the same clinic. (Holley et al., 2011; Sutherland et al., 2014)

Is a mouthpiece as good as CPAP?

CPAP removes more events per hour, about 6 more in pooled trials. But people wear a mouthpiece longer each night, so over a whole night the two land close together: 49.9% versus 49.1% of apnea removed in a 2026 study of 94 patients who tried both. (Dieltjens et al., 2026; Ramar et al., 2015)

What are the side effects of a sleep apnea mouthpiece?

Mostly mild and early. Across 28 studies the most common were extra saliva (33.3%), bite changes (30.2%), jaw muscle pain (22.9%), tooth discomfort (20.2%) and dry mouth (18.3%). Over about a decade, half of long-term users in one study had back teeth that no longer met. (Mansour et al., 2024; Pliska et al., 2014)

How do I know if my mouthpiece is working?

Only a sleep test with the device in can tell you. At Mayo Clinic, 89% of snoring patients said their snoring improved, but only about 20% of patients reached fewer than 10 events an hour. Sleep and dental academies advise a follow-up sleep test after fitting. (Hamza et al., 2026; Ramar et al., 2015)

Does Medicare cover an oral appliance for sleep apnea?

Yes, for a custom device supplied by a dentist when a sleep test shows 15 events per hour or more, or 5 to 14 with symptoms such as daytime sleepiness or high blood pressure. Above 30 events per hour, Medicare also requires that you cannot tolerate CPAP. (CMS LCD L33611, 2021)

Do boil-and-bite sleep apnea mouthguards work?

Not as well. In a randomized crossover trial of 35 people with mild sleep apnea, a custom-made device succeeded in 60% versus 31% for a boil-and-bite device, and 82% of patients preferred the custom one. The joint sleep and dental guideline recommends custom, adjustable devices. (Vanderveken et al., 2008; Ramar et al., 2015)

How long does a sleep apnea mouthpiece last?

Plan on repairs and eventual replacement. In a 2026 study of 219 patients, 26.5% needed a new device made because the old one broke, and only 81.1% got through three years without a breakage remake. Fit and effect should also be rechecked, since effect can fade as years pass. (Kakuda et al., 2026)

How We Researched This

This analysis draws on the joint American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine clinical practice guideline, meta-analyses of randomized trials, head-to-head trials published through October 2026, long-term cohorts, the Medicare coverage policy for oral appliances and the FDA approval record for tirzepatide. Sixty-one sources were reviewed and forty-three are cited. Every figure was checked against its source page on the research date. PubMed abstract pages, which block automated readers, were confirmed through the National Library of Medicine's E-utilities service; PubMed Central pages were re-read after rate limiting; PDFs were read as extracted text. One three-year breakage figure that appeared only in a full text the publisher would not serve was replaced with the published three-year survival estimate. Success rates are always reported with their definition (AHI under five, under ten, or a halving of the score) because the three are not interchangeable. Limitations: several key trials have authors with ties to device or CPAP makers, including ResMed, SomnoMed and ProSomnus; the whole-night comparison rests on a non-randomized study of ninety-four patients and a small earlier cohort; retesting and long-term drift figures come from single practices or small studies; and no figures specific to the Texas Panhandle were found, so none are given. Research stages: Reddit, YouTube, TikTok and web searches for recent discussion ran at full coverage, though the relevance filter dropped unrelated Reddit and YouTube results on one recency query; the backlink format analysis used three hand-picked dental publishers because automatic competitor discovery returned only very large health sites.

Sources

1. Comparative effectiveness of oral appliances and continuous positive airway pressure: a prospective non-randomized study using a non-inferiority framework. Dieltjens et al. American journal of respiratory and critical care medicine, 2026.
2. Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015. Ramar et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2015.
3. Effects of mandibular advancement devices vs. CPAP on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials. Cheng et al. Frontiers in neurology, 2026.
4. Efficacy of an adjustable oral appliance and comparison with continuous positive airway pressure for the treatment of obstructive sleep apnea syndrome. Holley et al. Chest, 2011.
5. The use of oral appliances in obstructive sleep apnea: a retrospective cohort study spanning 14 years of private practice experience. Mintz and Kovacs. Sleep & breathing = Schlaf & Atmung, 2018.
6. Clinical and craniofacial predictors of patient-reported and respiratory outcomes with oral appliance therapy. Hamza et al. Sleep medicine, 2026.
7. Breakage-Related Remanufacture of Mandibular Advancement Devices in Patients With Obstructive Sleep Apnea: A Retrospective Study of 219 Patients. Kakuda et al. Cureus, 2026.
8. Effect of mandibular advancement appliance use on oral and periodontal health in patients with OSA: a systematic review. Mansour et al. Sleep & breathing = Schlaf & Atmung, 2024.
9. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Phillips et al. American journal of respiratory and critical care medicine, 2013.
10. Continuous positive airway pressure and mandibular advancement splints: the CHOICE multicentre, open-label randomised clinical trial. Hamoda et al. The European respiratory journal, 2025.
11. Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Vanderveken et al. Thorax, 2013.
12. Objectively measured vs self-reported compliance during oral appliance therapy for sleep-disordered breathing. Dieltjens et al. Chest, 2013.
13. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Weaver and Grunstein. Proceedings of the American Thoracic Society, 2008.
14. CPAP Therapy Termination Rates by OSA Phenotype: A French Nationwide Database Analysis. Pepin et al. Journal of clinical medicine, 2021.
15. Trends in CPAP adherence over twenty years of data collection: a flattened curve. Rotenberg et al. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2016.
16. Predictors of long-term effectiveness to mandibular repositioning device treatment in obstructive sleep apnea patients after 1000 days. Attali et al. Sleep medicine, 2016.
17. Long-term compliance and side effects of oral appliances used for the treatment of snoring and obstructive sleep apnea syndrome. de Almeida et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2005.
18. Long-term obstructive sleep apnea therapy: a 10-year follow-up of mandibular advancement device and continuous positive airway pressure. Uniken Venema et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2020.
19. Treatment of OSA using mandibular advancement versus CPAP in improving cardiovascular health. Ou et al. The American journal of medicine, 2026.
20. Oral appliance treatment for obstructive sleep apnea: an update. Sutherland et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014.
21. Oral appliances for snoring and obstructive sleep apnea: a review. Ferguson et al. Sleep, 2006.
22. Efficacy of Oral Appliance for Mild, Moderate, and Severe Obstructive Sleep Apnea: A Meta-analysis. Liao et al. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024.
23. A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome: the ORCADES study. Vecchierini et al. Sleep medicine, 2016.
24. Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis. Nanda et al. The Annals of otology, rhinology, and laryngology, 2025.
25. Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea. Sharples et al. Sleep medicine reviews, 2016.
26. CPAP vs Mandibular Advancement Devices and Blood Pressure in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-analysis. Bratton et al. JAMA, 2015.
27. Mandibular Advancement vs CPAP for Blood Pressure Reduction in Patients With Obstructive Sleep Apnea. Ou et al. Journal of the American College of Cardiology, 2024.
28. Mandibular Advancement Device versus CPAP in Severe Obstructive Sleep Apnea. Colpani et al. Journal of dental research, 2026.
29. Long-term oral appliance therapy in obstructive sleep apnea syndrome: a controlled study on temporomandibular side effects. Doff et al. Clinical oral investigations, 2012.
30. Obstructive sleep apnea and mandibular advancement splints: occlusal effects and progression of changes associated with a decade of treatment. Pliska et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014.
31. Survey of oral appliance practice among dentists treating obstructive sleep apnea patients. Loube and Strauss. Chest, 1997.
32. Effect of a titration polysomnogram on treatment success with a mandibular repositioning appliance. Almeida et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009.
33. Comparison of Three Mandibular Advancement Device Designs in the Management of Obstructive Sleep Apnea: A Retrospective Study. Sangalli et al. Journal of Dental Sleep Medicine, 2022.
34. Long-Term Oral Appliances for Moderate to Severe Sleep Apnea Syndrome Tended to Lose Efficacy. Buiret and Chidiac. Journal of Sleep Medicine and Disorders, 2020.
35. Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data. Vecchierini et al. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021.
36. Japanese Cross-Sectional Multicenter Survey (JAMS) of Oral Appliance Therapy in the Management of Obstructive Sleep Apnea. Okuno et al. International journal of environmental research and public health, 2019.
37. Mandibular advancement devices in 630 men and women with obstructive sleep apnea and snoring: tolerability and predictors of treatment success. Marklund et al. Chest, 2004.
38. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Vanderveken et al. American journal of respiratory and critical care medicine, 2008.
39. Oral Appliances for Obstructive Sleep Apnea (L33611). CMS LCD L33611. Centers for Medicare & Medicaid Services, 2021.
40. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Malhotra et al. The New England journal of medicine, 2024.
41. FDA Approves First Medication for Obstructive Sleep Apnea. U.S. Food and Drug Administration. FDA, 2024.
42. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Benjafield et al. The Lancet. Respiratory medicine, 2019.
43. Hidden Health Crisis Costing America Billions: Underdiagnosing and Undertreating Obstructive Sleep Apnea Draining Healthcare System. American Academy of Sleep Medicine. AASM, 2016.